|
US MID CAP |
|
|||||
As of 4 July 2025 The component universe of the IQ Candriam ESG US Mid Cap Index begins with companies that comprise the Solactive GBS United States 400 Index. Companies, within this eligible universe, are then analyzed and assigned a score based on Candriam's Best-in-Class approach which combines Micro Analysis (stakeholders management) and Macro Analysis (Exposure to Global Sustainability Trends). A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
ACUITY BRANDS INC
BELLRING BRANDS INC
C H ROBINSON WORLDWIDE INC
DAVITA INC
ELASTIC NV
F5 INC
GAP INC/THE
H&R BLOCK INC
INFORMATICA INC
JACK HENRY & ASSOCIATES INC
KIMCO REALTY CORP
LAMB WESTON HOLDING INC
MADRIGAL PHARMACEUTICALS INC
NEUROCRINE BIOSCIENCES INC
OLD REPUBLIC INTL CORP
PAYCOM SOFTWARE INC
QIAGEN NV
RALPH LAUREN CORP
SAREPTA THERAPEUTICS INC
TAPESTRY INC
UDR INC
VAIL RESORTS INC
WALGREENS BOOTS ALLIANCE INC
XPO INC
YUM CHINA HOLDINGS INC
ZILLOW GROUP INC - A CLASS |
|||||
CANDRIAM 2019 |
|||||
|
About CANDRIAM Candriam is a leading pan-European multi-specialist asset manager with a 20-year track record and a team of 500 experienced professionals. Candriam has established management centers in Luxembourg, Paris, Brussels and London, and has experienced client relationship managers covering Continental Europe, the UK, the Middle East and Australia. Its investment solutions cover five key areas: fixed income, equities, alternatives, sustainable investments and advanced asset allocation. Through conviction-driven investment solutions, Candriam has earned a reputation for delivering innovation and strong performance to a long-standing, diversified client base in over 20 countries. This website, its contents and all relating intellectual property rights and know-how (together the "Information") are the property of Candriam. It may not be reproduced in whole or in part without prior written permission of Candriam. The Information may not be used without Candriam's prior written approval to create indexes, risk models or analytics, nor to verify or correct data or to use in connection with the issuing, offering, managing or marketing of any securities, portfolios, investment strategies, financial products or any other investment vehicle. None of the Information is intended to constitute investment advice or a recommendation regarding any investment decision. Although Candriam carefully selects the data and its sources, errors or omissions cannot be excluded a priori. The Information is therefore provided strictly on an "as is" basis and the user of the Information shall bear any and all risks pertaining to any use thereof. NONE OF CANDRIAM OR ANY OF ITS SUBSIDIARIES OR ITS OR THEIR DIRECT OR INDIRECT SUPPLIERS OR ANY THIRD PARTY INVOLVED IN THE MAKING OR COMPILING OF THE INFORMATION (EACH, A "CANDRIAM PARTY") MAKES ANY WARRANTIES OR REPRESENTATIONS AND, TO THE MAXIMUM EXTENT PERMITTED BY LAW, EACH CANDRIAM PARTY HEREBY EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES, INCLUDING WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. WITHOUT LIMITING ANY OF THE FOREGOING AND TO THE MAXIMUM EXTENT PERMITTED BY LAW, IN NO EVENT SHALL ANY OF THE CANDRIAM PARTIES HAVE ANY LIABILITY REGARDING ANY OF THE INFORMATION FOR ANY DIRECT, INDIRECT, SPECIAL, PUNITIVE, CONSEQUENTIAL (INCLUDING LOST PROFITS) OR ANY OTHER DAMAGES EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES. The foregoing shall not exclude or limit any liability that may not by applicable law be excluded or limited. For any queries, click here. |